R.P. Chiacchierini & Associates, LLC

Statistical and Regulatory Consulting

 

15825 Shady Grove RoadSuite 30Rockville, MD  20850

(240) 683-3738 – Office • (240) 683-9236 – Facsimile

 

The professionals at R.P. Chiacchierini & Associates have a unique depth and breadth of experience in all aspects of statistical consulting and regulatory affairs.  R.P. Chiacchierini & Associates offers a full range of services for device and biologic products.

Services

 

Known for its staff of former FDA senior management, policy makers, reviewers and industry personnel, the professional staff of R.P. Chiacchierini & Associates has assisted over 700 domestic and international clients.  We have first-hand knowledge of how the FDA views submissions and regulatory issues.  In fact, our principals actually wrote and approved many of the processes and policies currently in use by the FDA.

 

Our services include:

 

Ø      Device Regulatory Affairs

Ø      Biostatistical Services

Ø      Quality Systems & Compliance

Ø      Biologics Regulatory Affairs

 

Professional CVs

 

Ø      Richard P. Chiacchierini, PhD

Ø      Richard E. Lippman, OD, FAAO

 

Device Regulatory Affairs

 

The regulatory services provided to our clients (sponsors of medical devices) span a broad range of diagnostic and therapeutic specialties.  Our capabilities include developing regulatory strategies for successful submissions, preparing plans for FDA interactions and resource planning.  We can prepare an entire regulatory submission, individual sections of a submission, or simply review the submission the sponsor has prepared.

 

Our services include:

 

Ø      Strategic regulatory consulting and planning, including:

 

·      Development of preclinical and clinical trial design

·      Medical device classification

·      Submission classification for products with combined regulatory status

·      Interpretation of legislation, regulations, and guidelines, including import and export applications

·      Regulatory review of advertising and promotional material

·      Due diligence and consultation with venture communities and law firms on acquisition and compliance issues

·      Guidance on access to investigational devices during regulatory application preparation and review

 

Ø      FDA Submission: Complete or partial submission management, preparation and evaluation (E.G., IDEs, 510(k)s, PMAs, Supplements, Updates, Amendments, Petitions, etc.).

 

Ø      FDA Representation: Preparation and coordination of meetings with regulatory authorities including “relationship” guidance and panel meetings.

 

Ø      Post-market surveillance program evaluation and guidance, including post-approval studies, safety issues and alerts, and labeling review.

 

Ø      Humanitarian Device Exemption guidance and assistance.

 

Statistical Services

 

The Statistical Services group provides statistical support for device and biologic products.  Our statisticians, former FDA and industry professionals have decades of experience in a wide range of therapeutic areas.  We can provide full service from a study design to final report and representation or provide services on a consultancy basis.  However, when our services are utilized, our senior-level staff is directly involved and the client benefits from their expertise.

 

Statistical services include:

 

Ø      Preparation of responses to FDA inquiries regarding statistical issues or deficiencies

Ø      Preparation and coordination of meetings with regulatory authorities

Ø      Assistance in protocol development, including refinement of research questions, study design, sample size justification, and description of statistical analysis methods

Ø      Assistance with product development strategies to optimize likelihood of regulatory approval

Ø      Pre-clinical and clinical study design and analysis

Ø      Statistical analysis, programming and reports

Ø      Product applications and guidelines

Ø      FDA relationship guidance and dispute resolution

Ø      Performance of interim analysis for regulatory authorities and Data Safety Monitoring Boards

Ø      Comprehensive final data analysis and report suitable for inclusion in regulatory applications, submissions, presentation and publication

Ø      Support for preparation of regulatory and submissions

Ø      Computerized patient randomization

Ø      Design, analysis and interpretation of experimental pre-clinical studies

Ø      Design of experiments for manufacturing in-process, end-stage quality control, and product development and evaluation

 

Quality Systems & Compliance

 

R.P. Chiacchierini & Associates, with support from affiliated consultants, offers numerous services relating to quality systems and compliance for medical devices and biologic products.  These services include:

 

Quality Systems:

 

¨      The design, development and implementation of complete or partial quality systems that satisfy FDA, ISO 9000 and EN 46000 requirements, including Standard Operation Procedures, QA manuals and clinical trial systems, Design control systems, corrective action systems and product compliant reporting systems.

¨      CE Mark preparation and submissions

¨      Verification and validation assessments

¨      Process validation review and assistance

¨      Statistical process control

¨      Internal Quality Systems Audits

¨      Due diligence audits for suppliers, potential suppliers, acquisitions and CROs

¨      Pharmaceutical and device facility design, including controlled environments for sterile and non-sterile products

 

Compliance:

 

¨      Audits of clinical data contained in regulatory submissions

¨      Quality assurance of internal operations, trial protocols/case report forms, sponsor to agency study reports and submissions, protocol implementation at trial sites and IRBs

¨      FDA compliance management, including FDA 483s, warning letters, consent decrees and recall strategies

¨      Assessment and preparation for regulatory inspections

¨      Assistance with agency representation and negotiation

 

Biologics Regulatory Services

 

R. P. Chiacchierini & Associates, with support from affiliated consultants, provides a broad range of regulatory and clinical consulting services to companies who are involved with or manufacture biologic products.

 

These services include:

 

¨      Strategic product development and regulatory planning

¨      Product development guidance

-     Blood and blood products

-     Blood banking and transfusion services

-     Infectious disease diagnostic test kits (e.g., serologic, NAT, markers, etc.)

-     Computer driven testing devices

-     Biologic devices and biologic/device combinations

-     Blood bank stand alone software

¨      Protocol development and implementation

¨      Study monitoring and auditing

 

¨      Regulatory submissions [IND, ELA/PLA, BLA, IDE, PMA, and 510(k)]

-      Strategy development and implementation

-      Document and submission preparation

-      FDA meeting coordination, preparation and assistance

¨      Facility evaluation for the production of biologic products

¨      Due diligence and consultation with the venture funding communities and law firms on acquisition, licensing, and compliance issues

 

 

 

 

Richard P. Chiacchierini, PhD

President and CEO

 

Dr. Chiacchierini has a long list of clients with successful product approvals and other FDA interactions.  The experience he brings to his clients spans eight years as a very successful consultant and 20 years in FDA senior management.  This combination allows him to guide his clients smoothly through successful FDA interactions.  He has an expert understanding of the types of clinical studies that must be conducted, the types of analyses necessary, the proper interpretation of the results, as well as an understanding of how to interpret FDA requirements and requests.  This regulatory insight, together with his strong statistical knowledge, gives his clients a consulting perspective that is difficult to duplicate.

 

Prior to forming R. P. Chiacchierini & Associates, Dr. Chiacchierini was with CL McIntosh & Associates as the Senior Vice President, Statistical Services.  Dr. Chiacchierini served with the FDA in various management positions.  From 1982 to 1994, he directed the Division of Biometric Sciences in the FDS’s Center for Devices and Radiological Health.  Dr. Chiacchierini’s Division was responsible for the statistical review of Investigational Devices Exemption (IDE), Pre-market Notification [510(k)] and pre-market Approval (PMA) applications.  With responsibility for program direction and policy, he developed and implemented a system of routine statistical of medical device submissions, including device bench and animal testing, clinical trials, and manufacturing process validation and optimization.  Dr. Chiacchierini also developed and implemented the Center’s programs for post-market surveillance.  He is the author and co-author of agency guidance documents (most of which are still in use today), and he has given numerous short courses and presentations on the design, conduct and analysis of device clinical trials for FDA submissions.

 

With an appointment from then Surgeon General C. Everett Koop, Dr. Chiacchierini was also Chief Scientist Officer in the Commissioned Corps of the United States Public Health Service from 1987 to 1991.

 

Dr. Chiacchierini obtained a BS (mathematics) for St. Bonaventure University, an MS (experimental statistics) from North Carolina State University, and a PhD (statistics) from Virginia Polytechnic Institute and State University.  He is a member of the American Statistical Society, Biometric Society, Regulatory Affairs Professional Society and the Food and Drug Law Institute.

 

 

 

Richard E. Lippman, OD, FAAO

VP Ophthalmic Product Regulatory Affairs

 

Dr. Lippman’s specialty is ophthalmic devices, and he has worked extensively with IOLs, contact lenses, ophthalmic lasers, refractive surgery devices, solutions, disinfection units and diagnostic products.  He assists medical device manufacturers with regulatory strategies and submissions, including IDEs, 510(k)s and PMAs.  Dr. Lippman spent eight years as a successful consultant with C. L. McIntosh & Associates before joining R. P. Chiacchierini & Associates.

 

In addition to his consulting experience, Dr. Lippman has many years of senior management experience with FDA’s division of Ophthalmic Devices, Office of Device Evaluation (ODE), and Center for Devices and Radiological Health (CDRH).  From 1986 to 1993, ad Director of this Division, he was responsible for managing the review of 510(k)s, IDEs, PMAs, and reclassification petitions or ophthalmic devices.  This included developing strategic approaches to device review, designing and implementing policy on new products, and managing the related Advisory Panel.

 

From 1984 to 1986, he was the Chief of the Contact Lens Branch in the same Division.  Prior to that, her served as a Clinical Medical Office.

 

Before joining the FDA, Dr. Lippman was Chief Optometrist at the US Public Health Service Hospital, Staten Island, New York.

 

Dr. Lippman earned a BA (biological sciences) at the University of Vermont and BS and OD degrees from the New England College of Optometry.  He has been awarded fellowship in the American Academy of Optometry.  In addition, Dr. Lippman is a practicing optometrist.